Eliglustat
Ended Awarded Last action
- Contract number
- 36C26020F0255
- Awardee
-
Genzyme Corporation UEI X2XMAQLR9DA8
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $204,743
Award facts
- Contract value 100% obligated
- $204,743.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$16,251 | |
| Other Administrative Action | $0 | |
| Original award | $220,994 |
About this award
Genzyme Corporation, operating through its Sanofi Genzyme division and Genzyme Therapeutics business unit, has been awarded a $204,743.40 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) prime vendor contract vehicle. The order calls for the delivery of the drug eliglustat to the Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 in Cambridge, Massachusetts by February 25, 2021. No set-aside designation was applied to this award. The funding agency, the Department of Veterans Affairs, operates one of the largest health care systems in the United States and works to provide medical services to eligible military veterans.
Quick answers
Who was awarded contract 36C26020F0255?
36C26020F0255 was awarded to Genzyme Corporation by Veterans Integrated Service Network 20 (Veterans Health Administration) on February 25, 2020.
How much is contract 36C26020F0255 worth?
The government has obligated $204,743 on 36C26020F0255.
Is contract 36C26020F0255 an order under another contract?
Yes. 36C26020F0255 is a delivery order under 36F79719D0153, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26020F0255 competed?
The extent of competition for 36C26020F0255 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award